Acute Kidney Injury Clinical Trial
Official title:
Correlation of Brain and Thenar Muscle Oximetry During Cardiac Surgery With Parameters of Acute Kidney Injury in Adult Cardiac Surgical Patients Operated on Cardiopulmonary Bypass
Identification of risk factors of acute kidney injury (AKI). It is hypothesized that there might be a correlation between brain oximetry, tissue saturation of thenar muscle and marker of AKI in blood - neutrophil gelatinase-associated lipocalin (NGAL) - measured in blood samples during the first post-op day.
The day before operation, after verification of inclusion and exclusion criteria, the
visiting anesthesiologist will explain to the patient the aim of the study. By signing an
informed consent the patient will be recruited into the study. On the evening before
operation the patient will receive the statin in a dose taken along.
In the OR the anesthesiologist will verify if creatinin and blood urea nitrogen were measured
the day before operation - if not, a blood sample for the test will be obtained and sent to
perform the tests.
Before induction of anesthesia a bi-spectral index (BIS) probe will be placed on the patients
forehead. Above the BIS probe a INVOS(TM) probe for brain oximetry (5100 C Cerebral/Somatic
Oximeter, Somanetics, Medtronic) will be placed.
Brain oximetry by near infrared saturation (NIRS) and tissue saturation on thenar muscle will
be recorded before and during operation on nine timepoints.
As NIRS and thenar muscle saturation are non-routine non-invasive methods of intraoperative
monitoring, patient had to sign an informed consent to participate into the study, and ethic
committee approval for the study protocol was appealed and granted.
General anesthesia will be induced by: fentanyl 0.2 mg, propofol 0.5-1.5 mg/kg in bolus
200ml/godz.; and rocuronium - 0.5 mg/kg. After induction dexamethasone will be given in a
dose of 0,7-1 mg/kg. For conduction of anesthesia before cardiopulmonary bypass (CPB)
sevoflurane will be added to the inhaled mixture of air and oxygen. On CPB propofol will be
given iv. In case of hemodynamic instability after commencing CPB, which will require
catecholamines in a cumulative dose of > 1.5 standard, or in case of trouble to commence CPB,
propofol will be replaced by midazolam in a dose 0.2-0.3 mg/kg/hour.
During anesthesia, first post-operative day and hospital stay a total of 278 variables will
be recorded: hemodynamic parameters, iv fluid doses, inotropes, vasopressors, diuretics,
urine output, transfusions, etc.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05538351 -
A Study to Support the Development of the Enhanced Fluid Assessment Tool for Patients With Acute Kidney Injury
|
||
Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
Completed |
NCT03938038 -
Guidance of Ultrasound in Intensive Care to Direct Euvolemia
|
N/A | |
Recruiting |
NCT05805709 -
A Patient-centered Trial of a Process-of-care Intervention in Hospitalized AKI Patients: the COPE-AKI Trial
|
N/A | |
Recruiting |
NCT05318196 -
Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
|
||
Recruiting |
NCT05897840 -
Continuous Central Venous Oxygen Saturation Measurement as a Tool to Predict Hemodynamic Instability Related to Renal Replacement Therapy in Critically Ill Patients
|
N/A | |
Recruiting |
NCT04986137 -
Fractional Excretion of Urea for the Differential Diagnosis of Acute Kidney Injury in Cirrhosis
|
||
Terminated |
NCT04293744 -
Acute Kidney Injury After Cardiac Surgery
|
N/A | |
Completed |
NCT04095143 -
Ultrasound Markers of Organ Congestion in Severe Acute Kidney Injury
|
||
Not yet recruiting |
NCT06026592 -
Detection of Plasma DNA of Renal Origin in Kidney Transplant Patients
|
||
Not yet recruiting |
NCT06064305 -
Transcriptional and Proteomic Analysis of Acute Kidney Injury
|
||
Terminated |
NCT03438877 -
Intensive Versus Regular Dosage For PD In AKI.
|
N/A | |
Terminated |
NCT03305549 -
Recovery After Dialysis-Requiring Acute Kidney Injury
|
N/A | |
Completed |
NCT05990660 -
Renal Assist Device (RAD) for Patients With Renal Insufficiency Undergoing Cardiac Surgery
|
N/A | |
Completed |
NCT04062994 -
A Clinical Decision Support Trial to Reduce Intraoperative Hypotension
|
||
Terminated |
NCT02860130 -
Clinical Evaluation of Use of Prismocitrate 18 in Patients Undergoing Acute Continuous Renal Replacement Therapy (CRRT)
|
Phase 3 | |
Completed |
NCT06000098 -
Consol Time and Acute Kidney Injury in Robotic-assisted Prostatectomy
|
||
Not yet recruiting |
NCT05548725 -
Relation Between Acute Kidney Injury and Mineral Bone Disease
|
||
Completed |
NCT02665377 -
Prevention of Akute Kidney Injury, Hearttransplant, ANP
|
Phase 3 | |
Terminated |
NCT03539861 -
Immunomodulatory Biomimetic Device to Treat Myocardial Stunning in End-stage Renal Disease Patients
|
N/A |